Although a considerable body of biological and clinical data has been accumulated on the mood disorders and organic disorders of late life, only a handful of studies have focused on aging schizophrenia patients. Using the results of a comprehensive evaluation of all elderly patients admitted over a 30-month period to a 26-bed acute care geriatric unit, we compared the demographic, social, and clinical characteristics of schizophrenia patients, patients with recurrent major depression with and without psychotic features, and patients with primary degenerative dementia of the Alzheimer's type with and without delusions. The main findings of this study are that elderly schizophrenia patients were younger, more often African-American, more often single, and poorer than the other groups. A concomitant history of substance abuse and institutionalization as an outcome were more frequent among schizophrenia patients. Like the older depressed and demented patients, schizophrenia patients were predominantly female and commonly presented with several medical disorders. The potential significance of these findings is discussed in the context of the literature on the long-term outcome of schizophrenia.
Schizophrenia is affected by the aging process which, as in normal people, is capable of generating not only additional difficulties, but also amelioration and tranquilization. [Ciompi 1980, p. 618] Early in this century, psychoses in old age were considered by Emil Kraepelin "the darkest area of psychiatry" (cited in Pearlson and Rabins 1988) and were invariably attributed to either arteriosclerosis or central nervous system degeneration ). This conceptualization was radically changed in the late 1950s by a series of landmark studies performed by Roth and his collaborators (Roth and Morrissey 1952; Kay et al. 1955; Kay and Roth 1961; Kay 1963) . Following Kraepelin's (1919 Kraepelin's ( /1971 ) method, they studied all patients age 60 and older admitted to the Graylingwell psychiatric hospital (England). On the basis of presenting symptoms and outcome, all but a few patients could be classified in to one of five predefined groups: affective psychosis, late paraphrenia, acute confusion, and senile and arteriosclerotic psychoses. The syndromebased DSM-III-R (American Psychiatric Association 1987) remains congruent with this nosology of the psychotic mental disorders occurring in late life, although the designations have been changed: senile and arteriosclerotic psychoses have been renamed primary degenerative dementia (PDD) and multi-infarct dementia (MID); acute confusion corresponds to delirium; affective psychoses are now called mood disorders with psychotic features. Late paraphrenia was defined as an illness characterized by a well-organized paranoid delusional system as its most prominent feature, with or without auditory hallucinations, typically in the setting of a preserved personality and affective response. All of the patients presenting with this clinical picture had experienced the onset of illness after age 45 and the typical age at onset was after 60. Thus, Roth adopted the term "late paraphrenia" to emphasize both its late onset and its correspondence to the form of schizophrenia described by Kraepelin under the term "paraphrenia." Considering their clinical presentations, neuropsychological performances, and outcome, 1 Roth's patients with late paraphrenia would likely be given DSM-III-R diagnoses of schizophrenia, organic delusional disorder, or occasionally delusional (paranoid) disorder (Grahame 1984; Miller et al. 1986; Holden 1987; Miller and Lesser 1988; Hymas et al. 1989; Hint et al. 1991) . Studies adopting Roth's methodology conducted during the modern era of psychopharmacology have shown that his classification of the mental disorders in late life has withstood the test of time. Although the distribution of patients among Roth's diagnostic categories has changed, more than 90 percent of all elderly patients admitted to psychiatric hospitals still fit into one of these categories (Blessed and Wilson 1982; Christie 1982; Christie and Wood 1990) , and a high proportion of those who do not are patients "with long established diagnoses such as ' On neuropsychological testing, patients with late paraphrenia performed similarly to patients with affective psychosis and differently from patients with senile psychosis. Regarding natural outcome at 6 months and 2 years, most patients with paraphrenia were alive but institutionalized, most patients with affective psychosis had been discharged, and patients with senile or arteriosclerotic psychoses were deceased. schizophrenia" (Christie and Wood 1990) .
As happened in the Kraepelinian era with midlife psychiatric disorders, the recognition of the heterogeneity of the mental disorders of late life and their classification allowed research to progress. However, although a considerable body of clinical and biological data has been accumulated on the mood disorders and organic disorders of late life, only a handful of studies have focused on elderly patients with schizophrenia. Since its omission in DSM-III (American Psychiatric Association 1980) and its "rediscovery" in DSM-III-R, lateonset schizophrenia (LOS)-defined as schizophrenia with onset after age 45-has been the focus of renewed interest. It is the topic of several reviews and studies (Lester 1982; Gold 1984; Grahame 1984; Marneros and Deister 1984; Rabins et al. 1984; Volavka 1985; Harris and Jeste 1988; Jeste et al. 1988; Pearlson et al. 1989; Castle and Howard 1992) and of this special issue of the Bulletin. By contrast, with a few notable exceptions (Bleuler 1978; Tsuang et al. 1979; Ciompi 1980; Huber et al. 1980; Harding et al. 1987) , very little attention has been paid to-and as a result little is known about-what happens to patients with earlyonset schizophrenia (EOS) as they grow older. For instance, in a recently published geriatric psychiatry textbook (Sadavoy et al. 1990 ), the two paragraphs (33 lines) devoted to this topic mostly emphasize how little is known about the aging of schizophrenia patients. Many unanswered questions related to this topic were raised during the preneuroleptic era. Their answers remain crucial to the understanding of the pathogenesis of schizophrenia Slater and Roth 1969; Weinberger 1987) . For instance: How commonly does schizophrenia evolve into a "true" dementia? Do some schizophrenia patients achieve sustained remission in late life owing to the aging process (e.g., as a result of agerelated changes in dopaminergic neurotransmission), the natural course of the illness (e.g., the evolution of positive symptoms to negative symptoms), or treatment (e.g., treatment with neuroleptics or institutionalization)? Is schizophrenia a neurodevelopmental or a neurodegenerative disease (i.e., can we identify a fixed or an evolutive central nervous system [CNS] lesion)? What factors, besides possibly a higher incidence of suicide, are responsible for the lower life expectancy of schizophrenia patients?
To address some of these and other questions on schizophrenia in late life, we performed a naturalistic study characterizing the demographic, social, and clinical profiles of elderly schizophrenia patients admitted from the community to an acute care geriatric unit. To distinguish the demographic, social, and clinical characteristics specific to these patients from the characteristics of elderly patients suffering from nonschizophrenic psychotic disorders and other major psychiatric disorders of late life, we compared the schizophrenia patients with patients with recurrent major depression, with and without psychotic features, and with patients with primary degenerative dementia of the Alzheimer's type, with and without delusions.
Methods and Subjects
The Geriatric Clinical Research Unit (GCRU) is a 26-bed acute VOL 19, NO. 4, 1993 711 care unit for the assessment and treatment of late-life mental disorders at Western Psychiatric Institute and Clinic, a teaching psychiatric hospital that provides psychiatric care to a large urban catchment area and serves as a referral center for psychiatric patients from suburban and rural southwestern Pennsylvania. All patients age 50 or older who are admitted to the unit for at least 4 days receive a comprehensive evaluation performed by a multidisciplinary team consisting of an attending psychiatrist, a social worker, a physician's assistant (under the supervision of a geriatrician), an occupational therapist, a psychiatric nurse, and a trained research clinician, all with expertise in geriatric psychiatry Kunik et al. 1993 ). This diagnostic evaluation includes a psychiatric history and mental status examination, a social history, a medical history and physical examination, a battery of blood tests, a chest x-ray, an electrocardiogram, an electroencephalogram (EEG), CNS imaging -(magnetic resonance imaging [MRI] or computed tomography [CT] scan-when MRI is contraindicated because of the presence of metal parts or when the patient is unable to cooperate with the MRI procedures), and other tests as indicated by the patient's history or examination. All EEGs are visually graded by a trained electroencephalographer as grade 0 (normal), I, II, or III according to the criteria of the Mayo Clinic Classification System of EEG Abnormalities (Members of the Department of Neurology, Mayo Clinic 1991). MRIs and CTs are rated on the basis of radiologists' clinical reports according to a methodology described elsewhere ).
In addition, on admission and at discharge, a structured assessment is administered by a trained research clinician who is not involved in the clinical care of patients. This assessment yields ratings on several instruments including: the Global Assessment Scale (GAS; Endicott et al. 1976 Molloy et al. 1991) . During the study period, intraclass correlation coefficients measuring interrater reliability ranged from 0.78 to 0.99 for these measures. For this study, we also created two additional subscales based on selected BPRS items to assess specifically the severity of positive symptoms (BPRS items 4, 7, 8, 10, 11, 12, 15, and 17) and negative symptoms (BPRS items 3, 13, 14, and 16).
Shortly after a patient's discharge from the unit, consensus Axis I and Axis II diagnoses are established according to DSM-III-R. These research diagnoses are made at a weekly conference attended by three to six faculty psychiatrists and the research staff. All available information, including information obtained from the patient, family, primary care physicians, and old records, is considered. The diagnosis corresponding to the symptoms that precipitated the admission is recorded as the "primary psychiatric diagnosis." Additional Axis I and Axis II diagnoses are recorded as warranted. Medical problems are coded on Axis III according to the ICD-9-CM classification system (U.S. Department of Health and Human Services 1989), with the exception that mental disorders and diseases of the brain recorded on Axis I and Axis II are not duplicated.
For this study, we considered all patients age 50 and older who were admitted to the GCRU between September 2, 1989, and February 21, 1992; for patients who had more than one admission during the study period, only the most recent one was considered. We identified all patients whose primary DSM-III-R diagnosis was among the following five: schizophrenia, any type, EOS or LOS; major depression, recurrent (MD-R), without psychotic features; MD-R with psychotic features; primary degenerative dementia of the Alzheimer's type (PDD-AT), uncomplicated; PDD-AT with delusions. Demographic, social, and clinical characteristics of patients with schizophrenia were systematically compared with the characteristics of the patients from the four other groups. Patients with EOS and LOS were compared with each other for the variables for which schizophrenia patients differed significantly from at least one group of nonschizophrenia patients.
Categorical variables were compared with chi-square analysis or Fisher's exact test, as appropriate. When patients with MD-R with and without psychotic features did not differ significantly with respect to a specific categorical variable, the two groups were combined; similarly, when we compared categorical variables for which patients with uncomplicated PDD-AT and those with delusions did not differsignificantly, these patients were combined into one group.
Continuous variables were compared with one-way analysis of variance (ANOVA), or a nonparametric analog when appropriate, followed by Tukey's post hoc test when significant group effects were detected. Ratings obtained at admission or at discharge were compared between groups with repeated-measures ANOVA, or a nonparametric analog when appropriate, followed either by Tukey's post hoc test, when significant group X time interactions were detected, or by Newman-Keuls multiple comparisons procedures, when group effects without group X time interactions were detected. Ratings obtained at admission and at discharge were compared within groups with the paired t test or a nonparametric analog when appropriate. Unless indicated otherwise, all continuous variables are reported as means ± standard deviation. All tests were two-tailed.
Results
During the study period, 602 patients, age 50 and older, were admitted to the GCRU, of whom 232 were classified into one of the five defined groups: (1) EOS (« = 29) or LOS (n = 5); (2) MD-R without psychotic features (n = 80); (3) MD-R with psychotic features (« = 29); (4) PDD-AT, uncomplicated (n = 51); (5) PDD-AT with delusions (n = 38).
Sociodemographic Variables.
Schizophrenia patients had a mean age of 63 (± 7) and were on average 8 years younger than the depressed patients and 17 years younger than the demented patients (table 1) . Furthermore, the oldest patient in the schizophrenia group was 77; the oldest patients in the MD-R and PDD-AT groups were 95 and 96, respectively. As expected, schizophrenia patients typically experienced the onset of their illness in their twenties and thirties, on average 20 and 45 years earlier than the depressed and demented patients, respectively. With regard to sex, 76 percent of the schizophrenia patients were female; this proportion did not differ from that in the other groups, except for the patients with MD-R with psychotic features, of whom 59 percent were male. The majority of patients were white in all groups. How- ever, the proportion of AfricanAmericans was significantly higher among the schizophrenia patients (24%) than in any other group except for patients with PDD-AT with delusions.
Patients with schizophrenia were significantly more likely to have never married (38%) or to be separated or divorced (35%) than were patients in any other groups. In terms of years of education, patients with schizophrenia did not differ from patients with depression or dementia. The mean annual household income of the schizophrenia patients ($5,500 ± $3,700) was the lowest of any group, but because of large variances, the difference reached significance only in the comparison with depressed patients.
Clinical Variables. Among patients with schizophrenia, 18 percent had a history of one or more suicide attempts (table 2) . This proportion did not differ significantly from the proportion in the MD-R group but was significantly lower than the proportion in the PDD-AT group. Thirty-two percent of the schizophrenia patients had a diagnosis of current or past substance abuse or dependence, a significantly higher proportion than in any of the other four groups. Despite being significantly younger, schizophrenia patients did not differ from the demented or depressed patients in terms of mean number of Axis III diagnoses and Axis III diagnoses of sensory impairment, except for patients with MD-R without psychotic features, who received a significantly higher number of Axis III diagnoses. Twelve percent of the schizophrenia patients were given a clinical diagnosis of tardive dyskinesia, which is likely to reflect the presence of a moderate or severe movement disorder (research assessment and operationalized criteria for tardive dyskinesia that might have detected milder cases were not applied). This proportion was significantly higher than in any other group.
Outcome Variables and Dispositions. Patients with schizophrenia had a mean length of stay of 24 ±16 days, not significantly different from that of the other groups except for patients with MD-R with psychotic features, who had a significantly longer length of stay (table 3). In terms of cognitive impairment, schizophrenia patients (mean MMSE score on admission = 25 ± 6; mean score at discharge = 26 ± 3) did not differ significantly from the depressed patients and were significantly less impaired than the demented patients. In terms of global functioning, on admission the schizophrenia patients (mean GAS score = 26 ± 6) were comparable to the other groups except for patients with MD-R without psychotic features, who were significantly less impaired. At dis- 
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13(6) 14 (7) 22 (6) 31 (13) 15 (4) 12 (5) 45 (8) charge, the schizophrenia patients (mean GAS score = 45 ± 16) were significantly less impaired than patients with PDD-AT but significantly more impaired than patients with MD-R.
In terms of psychotic symptoms as measured by the BPRS, patients with schizophrenia, MD-R with psychotic features, and PDD-AT with delusions had comparable admission and discharge total scores. VOL 19, NO. 4, 1993 715 scores on item 15 (delusionality), and subscores on items measuring negative symptoms. However, on BPRS item 12 (hallucinations), schizophrenia patients had the highest mean score both on admission and at discharge; the differences were significant except in the comparison with patients with PDD-AT with delusions on admission.
Overall, despite being associated with significant improvement on scales measuring psychopathology, acute psychiatric hospitalization led the five groups to significant changes in living arrangements, resulting in more restrictive settings. Changes in living arrangements were the most pronounced for schizophrenia patients, of whom 71 percent were admitted from home but only 32 percent returned home. More than 80 percent of the schizophrenia patients who did not return home were transferred to a State hospital.
EEG and MRI Variables. The EEGs of patients with schizophrenia were comparable to the EEGs of patients with MD-R and were significantly less likely to be rated as abnormal than were the EEGs of patients with PDD-AT (table 4). The pattern was similar in terms of radiologic evidence of atrophy on MRI. By contrast, despite their significantly younger age, the schizophrenia patients did not differ from either the depressed or the demented patients in terms of radiologic evidence of cortical or subcortical infarct and leukoencephalopathy ("small vessel disease") on MRI.
EOS Versus LOS.
The 29 patients with EOS were significantly younger than the 5 patients with LOS (mean age at index = 62 ± 7 vs. 69 ± 6; df = 32; f = 2.18; p = 0.04; range = 50-77 vs. 60-76) and -by definition-had experienced the onset of their illness at an earlier age (mean age at onset = 27 ± 7 vs. 55 ± 11; range = 17-44 vs. 48-74). There was also a trend for patients with EOS to be more likely to have never married (13/29, 45%) than patients with LOS (0/5; Fisher's exact p = 0.06). Patients with LOS, compared with patients with EOS, presented on admission with significantly more florid psychotic symptoms. By discharge, however, they had experienced a significantly greater improvement in these symptoms, as revealed by group x time interactions in the analyses of BPRS total scores (LOS = 49.2 ± 8.4 to 26.2 ± 3.7 vs. EOS = 44.1 ± 8.9 to 36.2 ± 7.4; p = 0.0001) and positive symptoms subscores (LOS = 25.8 ± 7.2 to 9.8 ±1.6 vs. EOS = 20.3 ± 6.5 to 12.8 ± 8.5; p = 0.03). Patients with LOS also scored higher on admission and lower at discharge on BPRS items 12 and 15 (hallucinations and delusions, respectively); there was a trend for these differences to be significant for item 15 (p = 0.06). These symptomatic differences resulted in LOS patients receiving significantly lower admission GAS scores and higher discharge GAS scores (LOS = 24.8 ± 3.7 to 61.0 ± 16.9 vs. EOS = 26.3 ± 6.2 to 41.8 ± 14.5; group X time interaction, p = 0.01). None of the other comparisons between patients with EOS and patients with LOS revealed any significant difference or trend. 
Table 4. Electroencephalogram (EEG) and magnetic resonance imaging (MRI) variables

Discussion
This study systematically compared the demographic, social, and clinical characteristics of elderly schizophrenia patients with those of other elderly psychiatric patients. Regardless of diagnosis, all patients had received a comprehensive evaluation that resulted in a consensus research diagnosis based on the widely used and validated DSM-III-R criteria. This crosssectional and comparative approach to studying elderly schizophrenia patients allowed us to determine whether their characteristics were associated specifically with their illness or nonspecifically with the aging process in the context of severe psychiatric disability. Limitations of this study included the small number of elderly patients with schizophrenia, and in particular with LOS. All of our subjects were elderly patients who were admitted to an acute care psychiatric hospital and thus our results may not apply to older psychiatric patients being treated in the community or receiving long-term care in State hospitals. Our analysis of outcome was hindered by the brief duration of acute hospitalization and the lack of followup. Notwithstanding these limitations, the main findings of this study are that elderly schizophrenia patients were younger, more often African-American, more often single, and poorer. A concomitant history of substance abuse and institutionalization as an outcome were more frequent among schizophrenia patients. Like older patients from other groups, schizophrenia patients were predominantly female and commonly presented with several medical disorders. The potential significance of the most salient of these characteristics deserves comment.
Age and Medical Burden. Schizophrenia patients admitted from the community to our acute care geropsychiatric unit were younger than patients with either MD-R or PDD-AT. Given the markedly earlier onset of schizophrenia, one can expect schizophrenia patients to be overrepresented among the youngest geriatric patients ("the young-old"). However, among more than 600 elderly psychiatric patients admitted during a period of more than 2 years, not one schizophrenia patient was in his or her eighties, whereas 65 of the depressed and demented patients (28%) were in their eighties and nineties (x 2 = 59.2, df = 2, p < 0.001). This "deficit" of schizophrenia patients among "old-old" psychiatric patients admitted from the community could be accounted for by several alternative explanations.
First, in some patients, schizophrenia may "burn out," leading either to recovery or to a residual state characterized mostly by negative symptoms. As a result, old-old schizophrenia patients would no longer require admission to an acute care psychiatric hospital. This explanation is supported by the robust results of several longitudinal studies involving a total of close to 3,000 schizophrenia patients in Europe and the United States (Bleuler 1978; Tsuang et al. 1979; Ciompi 1980; Huber et al. 1980; Harding et al. 1987 ). These studies demonstrate that at least half of all schizophrenia patients recover or improve considerably over the course of decades. However, some of these patients are expected to become demented and to require psychiatric admissions owing to their inability to function in the community (Ciompi 1980) . During the study period, we admitted only one demented patient with a past history of schizophrenia.
A second explanation proposes that many old-old schizophrenia patients are living in institutions and therefore are not seen in acute care psychiatric hospitals. Congruent with the study reported by Ciompi (1980) , during which patients were followed for an average of 37 (± 13) years; the study of Huber et al. (1980) ; and a study of 657 institutionalized elderly schizophrenia patients (Goodman and Siegel 1986) , our data indicate that in late life, schizophrenia patients remain at high risk for institutionalization even when they have been able to live in the community for more than 30 years.
Finally, a third explanation attributes the observed "deficit" of schizophrenia patients among the old-old to the reduced life expectancy associated with schizophrenia that has been reported by several studies over the past 50 years (Slater and Roth 1969; Ciompi 1980; Tsuang et al. 1980; Black et al. 1985; Allebeck and Wistedt 1986) . The excess mortality associated with schizophrenia has been attributed in part to suicide (Ciompi 1980; Drake et al. 1985; Allebeck and Wistedt 1986 ). In our study, similar proportions of schizophrenia patients and depressed patients had histories of suicide attempts; however, this similarity does not exclude the possibility that young schizophrenia patients have a higher frequency of completed suicide. In the past, the excess mortality of schizophrenia patients was also attributed to infectious diseases, in particular to the tuberculosis (Ciompi 1980) that was endemic in some State hospitals before the antibiotic era (Slater and Roth 1969) . In our study, we found that despite being on aver-age 17 years younger, the schizophrenia patients had a medical burden comparable to that of the patients with PDD-AT.
Although our cross-sectional data do not allow us to prove or disprove any of these hypothesesthat is, stabilization of the psychotic state, institutionalization, and attrition due to increased mortality-we believe that all of them may contribute, in varying degrees, to the "deficit" in old-old schizophrenia patients.
Sex Ratio. The finding that more than three-fourths of our elderly schizophrenia patients were female has to be analyzed in the context of the recent literature emphasizing that schizophrenia affects both sexes equally (Flor-Henry 1985) . The recognized younger age at onset in males with schizophrenia, which results in a preponderance of females among schizophrenia patients with age at onset after 45 (Flor-Henry 1985; Pearlson and Rabins 1988) , cannot explain the preponderance of females in our sample: exclusion of the LOS patients (all of whom were female) reduces the proportion of females to males only slightly, to 21:29 (72%). One could argue that given the longer life expectancy of females, we should expect to see a preponderance of females in any sample of elderly people. However, this explanation alone cannot account for the higher proportion of females among our schizophrenia patients, given their fairly young mean age (63 ± 7). Furthermore, the proportion of females was similar among the demented and nonpsychotically depressed patients, who were on average 17 and 8 years older than the schizophrenia patients.
We hypothesize that the preponderance of females in our sample may be explained by factors similar to those discussed in the previous section to explain the absence of old-old schizophrenia patients: there may be differential rates of stabilization, institutionalization, and mortality for males and females with schizophrenia. For instance, one study has reported a death rate twice as high in male schizophrenia patients as in female schizophrenia patients (Affleck et al. 1976) . A review of 23 studies pertinent to suicide in schizophrenia (Drake et al. 1985) reported that young males account for 60-80 percent of suicides among schizophrenia patients. Some evidence also indicates that schizophrenia has a worse outcome in males (Huber et al. 1980) , resulting more often in long-term institutionalization (Flor-Henry 1985) . Obviously, these factors may not be independent; Ciompi (1980) proposed that premature death (including suicide) constitutes a selection process favoring the survival of patients with good outcomes. As a result, female patients may be overrepresented in samples of elderly patients.
Symptoms, Outcome, and Institutionalization. On admission, elderly schizophrenia patients presented mostly with positive symptoms, including florid delusions and hallucinations. Overall, negative symptoms and cognitive impairment were mild. Although psychotic patients with schizophrenia, depression, or degenerative dementia could not be distinguished on the basis of the severity of their delusions, patients with schizophrenia could be differentiated from demented patients by their grossly intact cognitive performances and from patients with depression by the presence of florid hallucinations. Clearly, in these patients, aging does not seem to have had the "quieting, stabilizing, or mitigating" influence reported to occur in many schizophrenia patients who survive to old age (Ciompi 1980) . This is not surprising, given that our subjects were selected on the basis of admission to an acute care hospital; they would not be expected to belong to the 50-60 percent of schizophrenia patients reported in longitudinal studies to have recovered or evolved to a residual stage (Bleuler 1978; Tsuang et al. 1979; Ciompi 1980; Huber et al. 1980; Harding et al. 1987) . These patients also do not belong to the 10-20 percent of schizophrenia patients who are expected to have spent most of their lives in institutions (Ciompi 1980) . In Ciompi's study, schizophrenia patients were polarized into two groups: a group of patients who had been almost continuously hospitalized and a group of patients who had been rarely and only transiently hospitalized. However, as they became older, Ciompi's patients who still required hospital care were less likely to need transient hospitalization and more likely to need longterm hospitalization. Thus, as discussed above, these results and our data indicate that elderly schizophrenia patients who have not fully recovered or stabilized into a mild residual state remain at high risk for institutionalization.
Specificity of LOS. Among more than 600 acutely ill elderly psychiatric patients, we identified only 5 patients with LOS, who represented less than 15 percent of the elderly schizophrenia patients. As a result, our power to identify differences between patients with EOS and those with LOS was limited. Despite this lack of power, we found that compared with patients with EOS, patients with LOS were more floridly symptomatic on admission but demonstrated a better response to neuroleptic treatment and thus were less symptomatic at discharge. These findings are congruent with the results of recent studies of patients with LOS (Marneros and Deister 1984; Rabins et al. 1984; Pearlson et al. 1989 ) and studies showing that, overall, positive symptoms tend to decrease as duration of illness increases (Ciompi 1980).
Conclusions
Our results suggest that schizophrenia remains a distinct disease in late life and that even though schizophrenia patients represent only a small fraction of elderly psychiatric patients, they consume a disproportionate amount of mental health resources. Thus, studies of schizophrenia in late life are of both scientific and public health importance. Future studies should include larger numbers of patients (in particular, patients with LOS) and should compare elderly schizophrenia patients living in the community with those living in State hospitals. Given the limitations of cross-sectional studies in assessing the impact of the aging process and the difficulties and costs of lengthy longitudinal studies, cross-longitudinal studies should contrast the outcomes (including death) of elderly, middleaged, and young schizophrenia patients during periods of 5 to 10 years. Finally, considering the growing body of findings on structural brain abnormalities associated with schizophrenia in younger patients (Bachneff 1991; Bosse et al. 1991; Bornstein et al. 1992; Degreef et al. 1992; Weinberger et al. 1992) and psychotic or nonpsychotic mental disorders in late life (Rabins et al. 1987 Breirner et al. 1990; Coffey et al. 1990; Churchill et al. 1991; Krull et al. 1991; Miller et al. 1991; Pearlson et al. 1991; Kumar et al. 1992; Lesser et al. 1992) , systematic MRI studies of schizophrenia in late life with volumetric quantification of relevant brain structures and careful grading of radiological lesions are needed.
